FOLFIRINOX regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin; Fluorouracil with Irinotecan Hydrochloride, Leucovorin Calcium and Oxaliplatin; Folfirinox Protocol; Folfirinox Regimen
Overview
FOLFIRINOX regimen refers to a regimen consisting of fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin used for the treatment of pancreatic cancer.[1]
Regimen
FOLLeucovorin calcium (Folinic acid)
FIFluorouracil
RIIrinotecan hydrochloride
OXOxaliplatin
Indications
References
- ↑ {{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C11764&ns=NCI_Thesaurus>Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M (2013). "The role of the FOLFIRINOX regimen for advanced pancreatic cancer". Curr Oncol Rep. 15 (2): 182–9. doi:10.1007/s11912-012-0290-4. PMID 23341367.
- ↑ Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M (2013). "The role of the FOLFIRINOX regimen for advanced pancreatic cancer". Curr Oncol Rep. 15 (2): 182–9. doi:10.1007/s11912-012-0290-4. PMID 23341367.